Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 7/20 | 0.53 |
| ▸ | OXTR | P30559 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.46 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.46 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.46 |
| ▸ | GHSR | Q92847 | 2/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.46 |
| ▸ | NNMT | P40261 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21164406 | 0.97 | HDAC4 (0.54) | HDAC4OXTRHDAC1HDAC3HDAC7 | |
| SCHEMBL22292161 | 0.97 | HDAC4 (0.56) | HDAC4OXTRHDAC1HDAC3HDAC7 | |
| SCHEMBL21164399 | 0.95 | OXTR (0.51) | HDAC4OXTRABCB1NNMT | |
| SCHEMBL22326373 | 0.94 | HDAC4 (0.57) | HDAC4OXTRHDAC1HDAC3HDAC7 | |
| SCHEMBL21164408 | 0.94 | OXTR (0.52) | HDAC4OXTRHDAC1HDAC3HDAC7 | |
| SCHEMBL22326367 | 0.93 | OXTR (0.53) | HDAC4OXTRHDAC1HDAC3HDAC7 | |
| SCHEMBL21164398 | 0.92 | OXTR (0.51) | HDAC4OXTRHDAC1HDAC3HDAC7 | |
| SCHEMBL22292162 | 0.91 | HDAC4 (0.54) | HDAC4OXTRHDAC1HDAC3HDAC7 | |
| SCHEMBL21164405 | 0.91 | OXTR (0.54) | HDAC4OXTRHDAC1HDAC3HDAC7 | |
| SCHEMBL22326366 | 0.91 | HDAC4 (0.54) | HDAC4OXTRHDAC1HDAC3HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10351602-B1 | Antimicrobial analogues of gramicidin S | UNIVERSITY OF SOUTH FLORIDA (US) | 2019-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351602-B1 | Antimicrobial analogues of gramicidin S | GMPS, AAAS, GNPDA1 | HDAC4 2862/4885OXTR 3605/4885HDAC1 3237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.